ARMISTICE CAPITAL, LLC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 15 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$427,000
-75.1%
885,000
-69.1%
0.03%
-74.1%
Q2 2019$1,714,000
-9.5%
2,860,000
-1.4%
0.11%
+3.8%
Q1 2019$1,894,000
+264.2%
2,900,000
+190.0%
0.10%
-15.4%
Q4 2016$520,0001,000,0000.12%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
KLINSKY STEVEN B 4,859,885$44,614,00020.33%
Senator Investment Group LP 448,679$4,119,0000.04%
HIGHLAND CAPITAL MANAGEMENT LP 162,177$1,489,0000.03%
Baker Brothers Advisors 350,000$3,213,0000.03%
Alyeska Investment Group, L.P. 94,131$864,0000.01%
SABBY MANAGEMENT, LLC 30,000$275,0000.01%
FMR LLC 1,302,070$11,953,0000.00%
MILLENNIUM MANAGEMENT LLC 15,427$142,0000.00%
BlackRock Investment Management, LLC 846$8,0000.00%
GOLDMAN SACHS GROUP INC 17,290$159,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders